DE69419408T2 - Tylosin enthaltende tieraerztliche zubereitungen mit verzoegerter wirkstoffabgabe - Google Patents

Tylosin enthaltende tieraerztliche zubereitungen mit verzoegerter wirkstoffabgabe

Info

Publication number
DE69419408T2
DE69419408T2 DE69419408T DE69419408T DE69419408T2 DE 69419408 T2 DE69419408 T2 DE 69419408T2 DE 69419408 T DE69419408 T DE 69419408T DE 69419408 T DE69419408 T DE 69419408T DE 69419408 T2 DE69419408 T2 DE 69419408T2
Authority
DE
Germany
Prior art keywords
active substance
preparations containing
delayed delivery
veterinary preparations
gelling agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69419408T
Other languages
English (en)
Other versions
DE69419408D1 (de
Inventor
Alan Patterson
Drew Holmes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norbrook Laboratories Ltd
Original Assignee
Norbrook Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Laboratories Ltd filed Critical Norbrook Laboratories Ltd
Application granted granted Critical
Publication of DE69419408D1 publication Critical patent/DE69419408D1/de
Publication of DE69419408T2 publication Critical patent/DE69419408T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69419408T 1993-03-24 1994-03-22 Tylosin enthaltende tieraerztliche zubereitungen mit verzoegerter wirkstoffabgabe Expired - Lifetime DE69419408T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939306106A GB9306106D0 (en) 1993-03-24 1993-03-24 Sustained release veterinary composition
PCT/GB1994/000578 WO1994021267A1 (en) 1993-03-24 1994-03-22 Tylosin containing sustained release veterinary compositions

Publications (2)

Publication Number Publication Date
DE69419408D1 DE69419408D1 (de) 1999-08-12
DE69419408T2 true DE69419408T2 (de) 1999-10-28

Family

ID=10732660

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69419408T Expired - Lifetime DE69419408T2 (de) 1993-03-24 1994-03-22 Tylosin enthaltende tieraerztliche zubereitungen mit verzoegerter wirkstoffabgabe

Country Status (23)

Country Link
EP (1) EP0689444B1 (de)
JP (1) JPH08508032A (de)
KR (1) KR100283369B1 (de)
CN (1) CN1096268C (de)
AT (1) ATE181834T1 (de)
AU (1) AU669435B2 (de)
BG (1) BG62352B1 (de)
BR (1) BR9406202A (de)
CA (1) CA2158662C (de)
DE (1) DE69419408T2 (de)
DK (1) DK0689444T3 (de)
ES (1) ES2135568T3 (de)
FI (1) FI954447A (de)
GB (1) GB9306106D0 (de)
GR (1) GR3031293T3 (de)
HU (1) HUT73424A (de)
IL (1) IL109053A (de)
NO (1) NO953647L (de)
NZ (1) NZ262756A (de)
PE (1) PE7595A1 (de)
PL (1) PL175127B1 (de)
RO (1) RO114738B1 (de)
WO (1) WO1994021267A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2130069B1 (es) * 1997-04-10 2000-03-01 Basf Labiana S A Preparacion farmaceutica con liberacion retardada del producto activo.
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
PT1558263E (pt) * 2002-10-25 2006-10-31 Intervet Int Bv Composicao farmaceutica de libertacao prolongada
AU2021396978A1 (en) 2020-12-08 2023-02-23 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2105589B (en) * 1981-09-11 1985-10-23 Wellcome Found Injectable suspensions containing maleic acid or a salt thereof as a stabilising agent
AU555304B2 (en) * 1982-04-05 1986-09-18 Merck Sharp & Dohme Limited Stabilization of drugs in alginic acid and magnesium hydroxide granules
US4597969A (en) * 1982-04-05 1986-07-01 Merck Sharp & Dohme Stabilization of unstable drugs or food supplements
US4994227A (en) * 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation
DE3772415D1 (de) * 1986-03-10 1991-10-02 American Cyanamid Co Verfahren zur herstellung einer bolus-formulierung mit verzoegerter freisetzung.

Also Published As

Publication number Publication date
DK0689444T3 (da) 1999-11-22
NO953647D0 (no) 1995-09-15
ATE181834T1 (de) 1999-07-15
GB9306106D0 (en) 1993-05-12
JPH08508032A (ja) 1996-08-27
NZ262756A (en) 1997-06-24
HUT73424A (en) 1996-07-29
AU669435B2 (en) 1996-06-06
BG100078A (bg) 1996-07-31
FI954447A (fi) 1995-11-15
PL310804A1 (en) 1996-01-08
IL109053A0 (en) 1994-06-24
WO1994021267A1 (en) 1994-09-29
RO114738B1 (ro) 1999-07-30
BR9406202A (pt) 1995-12-12
EP0689444A1 (de) 1996-01-03
CA2158662C (en) 2009-06-30
PL175127B1 (pl) 1998-11-30
CA2158662A1 (en) 1994-09-29
HU9502700D0 (en) 1995-11-28
DE69419408D1 (de) 1999-08-12
CN1096268C (zh) 2002-12-18
KR100283369B1 (ko) 2001-03-02
ES2135568T3 (es) 1999-11-01
BG62352B1 (bg) 1999-09-30
NO953647L (no) 1995-11-22
IL109053A (en) 1999-09-22
GR3031293T3 (en) 1999-12-31
CN1123525A (zh) 1996-05-29
PE7595A1 (es) 1995-04-25
AU6262194A (en) 1994-10-11
KR960700732A (ko) 1996-02-24
FI954447A0 (fi) 1995-09-20
EP0689444B1 (de) 1999-07-07

Similar Documents

Publication Publication Date Title
ES2529167T3 (es) Método para utilizar lípidos neutros para modificar la liberación in vivo desde liposomas multivesiculares
AU4275597A (en) Erythropoietin drug delivery system
FI872481A (fi) Kiinteä, hallitusti vapauttava lääkeaineen kantoaineena käytettävä matriisi
NZ512287A (en) Pharmaceutical compositions comprising a lipophilic drug in a propylene glycol ester of a higher fatty acid carrier, where 60% of the ester is a monoester
AR006308A1 (es) Sistema dispensador; un metodo para estabilizar una composicion; una composicion acuosa y el uso del sistema dispensador.
CA2063576A1 (en) Slow release vehicles for minimizing skin irritancy of topical compositions
ES2186715T3 (es) Uso de un tensioactivo lipofilico en una composicion farmaceutica.
EP2106787A3 (de) Biologisch abbaubare Blockcopolymer-Zusammensetzungen zur Arzneimittelabgabe
NZ330369A (en) aqueous medicaments containing 9-hydroxy-risperidone fatty acid ester
SI1187601T1 (sl) Novi pripravek in dajalna oblika, ki obsega kislinsko labilen inhibitor protonske crpalke
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
UA27058C2 (uk) Фармацевтичhа композиція, що призhачеhа для одержаhhя порошків або шипучих таблеток, яка містить ефективhу кількість ібупрофеhу, фармацевтичhий препарат hа її осhові та спосіб його одержаhhя
DE69215770D1 (de) Pelletförmige Zusammensetzung, die Wirkstoffe enthält, die nicht geschützt sind gegen Abbau im Pansen von Wiederkäuern zusammen mit Wirkstoffen, die geschützt sind gegen Abbau im Pansen von Wiederkäuern
MY132911A (en) Clear, injectable solution of an anesthetic compound
AU692801B2 (en) Pharmaceutical compositions comprising a staurosporine as active ingredient.
DE69419408D1 (de) Tylosin enthaltende tieraerztliche zubereitungen mit verzoegerter wirkstoffabgabe
ES2111102T3 (es) Formulaciones cosmeticas y dermatologicas con un contenido activo en acido cis-urocaninico.
TR199902748T2 (xx) Uzun s�re etkili antimikrobik maddelerle ilgili geli�meler
WO2001049117A3 (en) An anti-viral lotion composition and a lotioned tissue product
IT1255076B (it) Microsfere biodegradabili ad uso farmaceutico e cosmetico

Legal Events

Date Code Title Description
8364 No opposition during term of opposition